1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Rising Incidences of Breast Cancer 6.1.2 Risisng Investments in R&D of Breast Cancer Diagnostics 6.1.3 Governments Efforts to Incresse Awareness 6.2 Market Restraints 6.2.1 High Cost of Imaging Systems 6.2.2 Errors and Side Effects Associated with Breast Screening 6.2.3 Stringent Regulations 7. Market Segmentation 7.1 By Type of Imaging Modalities 7.1.1 Mammography 7.1.2 MRI 7.1.3 Tomosynthesis 7.1.4 Ultrasound 7.1.5 Molecular Breast Imaging 7.1.6 Optical Breast Imaging 7.1.7 Ductography 7.1.8 Others 7.2 By Geography 7.2.1 North America 7.2.1.1 United States 7.2.1.2 Canada 7.2.1.3 Mexico 7.2.2 Europe 7.2.2.1 France 7.2.2.2 Germany 7.2.2.3 United Kingdom 7.2.2.4 Italy 7.2.2.5 Spain 7.2.2.6 Rest Of Europe 7.2.3 Asia-Pacific 7.2.3.1 China 7.2.3.2 Japan 7.2.3.3 India 7.2.3.4 Australia & New Zealand 7.2.3.5 South Korea 7.2.3.6 Rest of Asia-Pacific 7.2.4 Middle East & Africa 7.2.4.1 GCC 7.2.4.2 South Africa 7.2.4.3 Rest of the Middle East & Africa 7.2.5 South America 7.2.5.1 Brazil 7.2.5.2 Argentina 7.2.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Barco 9.2 Dilon Diagnostics 9.3 Dune 9.4 GE Healthcare 9.5 Hologic 9.6 Philips Healthcare 9.7 Seimens Healthcare 9.8 Thor Labs 9.9 Toshiba Medical 9.10 List Not Exhaustive 10. Future of the Market

Barco, Dilon Diagnostics, Dune, GE Healthcare, Hologic, Philips Healthcare, Seimens Healthcare, Thor Labs, Toshiba Medical